{"id":271145,"date":"2018-09-28T08:07:07","date_gmt":"2018-09-28T08:07:07","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=271145"},"modified":"2018-09-28T08:07:07","modified_gmt":"2018-09-28T08:07:07","slug":"cloudbased-drug-discovery-platforms-market-research-industry-analysis-growth-size-share-trends-forecast-to-2025","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/cloudbased-drug-discovery-platforms-market-research-industry-analysis-growth-size-share-trends-forecast-to-2025_271145.html","title":{"rendered":"Cloud-Based Drug Discovery Platforms Market Research \u2013 Industry Analysis, Growth, Size, Share, Trends, Forecast to 2025"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Cloud-Based Drug Discovery Platforms”<\/div>\n<\/div>\n<\/div>\n
This report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.<\/p>\n<\/div>\n

This report focuses on the global Cloud-Based Drug Discovery Platforms<\/strong><\/a> status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cloud-Based Drug Discovery Platforms development in United States, Europe and China.<\/p>\n

Among the various end users of cloud-based drug discovery platforms, pharmaceutical vendors are likely to be major stakeholders holding a high value share of the global cloud-based drug discovery platform market. An opportunity analysis of the global market reveals that leading software vendors have already adopted cloud-based drug discovery platforms to facilitate seamless research and development processes. As there is less adoption of these cloud-based platforms in several countries of the MEA, public and private ventures are taking initiatives to invest in the R&D process in this region. Moreover, the MEA cloud-based drug discovery platform revolution will witness significant growth in the coming years, thereby creating better opportunities for software vendors for growth and expansion.
Keeping the needs of consumers in mind, key players in the cloud-based drug discovery platform are offering flexible, cost-effective, and highly secure cloud-based storage options to consumers. Cloud-based drug discover platform runs at zero lag time, saving time and giving real-time access to users. This is another reason for the growing adoption of cloud-based drug discovery platform globally.
In 2017, the global Cloud-Based Drug Discovery Platforms market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.<\/p>\n

The key players covered in this study
IBM
Accenture
Tata Consultancy Services
SAS Institute
BioXcel
Cloud Pharmaceuticals
WuXi AppTec
Dassault System
Acelot<\/p>\n

Request a Sample Report<\/span> @<\/strong>  https:\/\/www.wiseguyreports.com\/sample-request\/3377968-global-cloud-based-drug-discovery-platforms-market-size<\/a><\/p>\n

Market segment by Type, the product can be split into
IaaS
PaaS
SaaS<\/p>\n

Market segment by Application, split into
Hospitals
Pharmaceutical Companies
Others<\/p>\n

Market segment by Regions\/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America<\/p>\n

The study objectives of this report are:
To analyze global Cloud-Based Drug Discovery Platforms status, future forecast, growth opportunity, key market and key players.
To present the Cloud-Based Drug Discovery Platforms development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.<\/p>\n

Table of Contents – Key Points
<\/strong><\/p>\n

1 Report Overview<\/strong>
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cloud-Based Drug Discovery Platforms Market Size Growth Rate by Type (2013-2025)
1.4.2 IaaS
1.4.3 PaaS
1.4.4 SaaS
1.5 Market by Application
1.5.1 Global Cloud-Based Drug Discovery Platforms Market Share by Application (2013-2025)
1.5.2 Hospitals
1.5.3 Pharmaceutical Companies
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered<\/p>\n

2 Global Growth Trends<\/strong>
2.1 Cloud-Based Drug Discovery Platforms Market Size
2.2 Cloud-Based Drug Discovery Platforms Growth Trends by Regions
2.2.1 Cloud-Based Drug Discovery Platforms Market Size by Regions (2013-2025)
2.2.2 Cloud-Based Drug Discovery Platforms Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities<\/p>\n

3 Market Share by Key Players<\/strong>
3.1 Cloud-Based Drug Discovery Platforms Market Size by Manufacturers
3.1.1 Global Cloud-Based Drug Discovery Platforms Revenue by Manufacturers (2013-2018)
3.1.2 Global Cloud-Based Drug Discovery Platforms Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Cloud-Based Drug Discovery Platforms Market Concentration Ratio (CR5 and HHI)
3.2 Cloud-Based Drug Discovery Platforms Key Players Head office and Area Served
3.3 Key Players Cloud-Based Drug Discovery Platforms Product\/Solution\/Service
3.4 Date of Enter into Cloud-Based Drug Discovery Platforms Market
3.5 Mergers & Acquisitions, Expansion Plans<\/p>\n

4 Breakdown Data by Type and Application<\/strong>
4.1 Global Cloud-Based Drug Discovery Platforms Market Size by Type (2013-2018)
4.2 Global Cloud-Based Drug Discovery Platforms Market Size by Application (2013-2018)<\/p>\n

…………..<\/p>\n

12 International Players Profiles<\/strong>
12.1 IBM<\/strong>
12.1.1 IBM Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cloud-Based Drug Discovery Platforms Introduction
12.1.4 IBM Revenue in Cloud-Based Drug Discovery Platforms Business (2013-2018)
12.1.5 IBM Recent Development
12.2 Accenture<\/strong>
12.2.1 Accenture Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cloud-Based Drug Discovery Platforms Introduction
12.2.4 Accenture Revenue in Cloud-Based Drug Discovery Platforms Business (2013-2018)
12.2.5 Accenture Recent Development
12.3 Tata Consultancy Services<\/strong>
12.3.1 Tata Consultancy Services Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cloud-Based Drug Discovery Platforms Introduction
12.3.4 Tata Consultancy Services Revenue in Cloud-Based Drug Discovery Platforms Business (2013-2018)
12.3.5 Tata Consultancy Services Recent Development
12.4 SAS Institute<\/strong>
12.4.1 SAS Institute Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cloud-Based Drug Discovery Platforms Introduction
12.4.4 SAS Institute Revenue in Cloud-Based Drug Discovery Platforms Business (2013-2018)
12.4.5 SAS Institute Recent Development
12.5 BioXcel<\/strong>
12.5.1 BioXcel Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cloud-Based Drug Discovery Platforms Introduction
12.5.4 BioXcel Revenue in Cloud-Based Drug Discovery Platforms Business (2013-2018)
12.5.5 BioXcel Recent Development
12.6 Cloud Pharmaceuticals<\/strong>
12.6.1 Cloud Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cloud-Based Drug Discovery Platforms Introduction
12.6.4 Cloud Pharmaceuticals Revenue in Cloud-Based Drug Discovery Platforms Business (2013-2018)
12.6.5 Cloud Pharmaceuticals Recent Development
12.7 WuXi AppTec<\/strong>
12.7.1 WuXi AppTec Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cloud-Based Drug Discovery Platforms Introduction
12.7.4 WuXi AppTec Revenue in Cloud-Based Drug Discovery Platforms Business (2013-2018)
12.7.5 WuXi AppTec Recent Development
12.8 Dassault System<\/strong>
12.8.1 Dassault System Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cloud-Based Drug Discovery Platforms Introduction
12.8.4 Dassault System Revenue in Cloud-Based Drug Discovery Platforms Business (2013-2018)
12.8.5 Dassault System Recent Development
12.9 Acelot<\/strong>
12.9.1 Acelot Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cloud-Based Drug Discovery Platforms Introduction
12.9.4 Acelot Revenue in Cloud-Based Drug Discovery Platforms Business (2013-2018)
12.9.5 Acelot Recent Development<\/p>\n

……Continued<\/strong><\/p>\n

Access Complete Report<\/strong> @<\/strong> https:\/\/www.wiseguyreports.com\/reports\/3377968-global-cloud-based-drug-discovery-platforms-market-size<\/a><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com
Contact Person:<\/strong> Norah Trent
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.wiseguyreports.com<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Cloud-Based Drug Discovery Platforms” This report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. This report focuses on the global Cloud-Based Drug … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-271145","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/271145","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=271145"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/271145\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=271145"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=271145"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=271145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}